Beta‐lactam versus beta‐lactam‐aminoglycoside combination therapy in cancer patients with neutropenia

BACKGROUND: Continued controversy surrounds the optimal empirical treatment for febrile neutropenia. New broad‐spectrum beta‐lactams have been introduced as single treatment, and classically, a combination of a beta‐lactam with an aminoglycoside has been used. OBJECTIVES: To compare beta‐lactam mono...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Paul, Mical, Dickstein, Yaakov, Schlesinger, Agata, Grozinsky‐Glasberg, Simona, Soares‐Weiser, Karla, Leibovici, Leonard
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2013
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457814/
https://ncbi.nlm.nih.gov/pubmed/23813455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003038.pub2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller